|
1
|
Seyfried TN and Huysentruyt LC: On the
origin of cancer metastasis. Crit Rev Oncog. 18:43–73. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mehner C, Hockla A, Miller E, Ran S,
Radisky DC and Radisky ES: Tumor cell-produced matrix
metalloproteinase 9 (MMP-9) drives malignant progression and
metastasis of basal-like triple negative breast cancer. Oncotarget.
5:2736–2749. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shay G, Lynch CC and Fingleton B: Moving
targets: Emerging roles for MMPs in cancer progression and
metastasis. Matrix Biol 44–46. 200–206. 2015. View Article : Google Scholar
|
|
4
|
Radisky ES, Raeeszadeh-Sarmazdeh M and
Radisky DC: Therapeutic potential of matrix metalloproteinase
inhibition in breast cancer. J Cell Biochem. 118:3531–3548. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bauvois B: New facets of matrix
metalloproteinases MMP-2 and MMP-9 as cell surface transducers:
Outside-in signaling and relationship to tumor progression. Biochim
Biophys Acta. 1825:29–36. 2012.PubMed/NCBI
|
|
6
|
Zhang M, Teng XD, Guo XX, Li ZG, Han JG
and Yao L: Expression of tissue levels of matrix metalloproteinases
and their inhibitors in breast cancer. Breast. 22:330–334. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wee P and Wang Z: Epidermal growth factor
receptor cell proliferation signaling pathways. Cancers. 9:522017.
View Article : Google Scholar
|
|
8
|
Sigismund S, Avanzato D and Lanzetti L:
Emerging functions of the EGFR in cancer. Mol Oncol. 12:3–20. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang Q, Chen X and Wang Z: Dimerization
drives EGFR endocytosis through two sets of compatible endocytic
codes. J Cell Sci. 128:935–950. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kyriakopoulou K, Kefali E, Piperigkou Z,
Bassiony H and Karamanos NK: Advances in targeting epidermal growth
factor receptor signaling pathway in mammary cancer. Cell Signal.
51:99–109. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yamamoto H, Higa-Nakamine S, Noguchi N,
Maeda N, Kondo Y, Toku S, Kukita I and Sugahara K: Desensitization
by different strategies of epidermal growth factor receptor and
ErbB4. J Pharmacol Sci. 124:287–293. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Conte A and Sigismund S: Chapter six-the
ubiquitin network in the control of EGFR endocytosis and signaling.
Prog Mol Biol Transl Sci. 141:225–276. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Salova AV, Belyaeva TN, Leontieva EA and
Kornilova ES: EGF receptor lysosomal degradation is delayed in the
cells stimulated with EGF-Quantum dot bioconjugate but earlier key
events of endocytic degradative pathway are similar to that of
native EGF. Oncotarget. 8:44335–44350. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tan X, Lambert PF, Rapraeger AC and
Anderson RA: Stress-induced EGFR trafficking: Mechanisms,
functions, and therapeutic implications. Trends Cell Biol.
26:352–366. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tomas A, Futter CE and Eden ER: EGF
receptor trafficking: Consequences for signaling and cancer. Trends
Cell Biol. 24:26–34. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Arakaki AKS, Pan WA, Lin H and Trejo J:
The α-arrestin ARRDC3 suppresses breast carcinoma invasion by
regulating G protein-coupled receptor lysosomal sorting and
signaling. J Biol Chem. 293:3350–3362. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu S, Wu X, Zong M, Tempel W, Loppnau P
and Liu Y: Structural basis for a novel interaction between TXNIP
and Vav2. FEBS Lett. 590:857–865. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Spindel ON, Yan C and Berk BC:
Thioredoxin-interacting protein mediates nuclear-to-plasma membrane
communication: Role in vascular endothelial growth factor 2
signaling. Arterioscler Thromb Vasc Biol. 32:1264–1270. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Park SY, Shi X, Pang J, Yan C and Berk BC:
Thioredoxin-interacting protein mediates sustained VEGFR2 signaling
in endothelial cells required for angiogenesis. Arterioscler Thromb
Vasc Biol. 33:737–743. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shin IS, Ahn KS, Shin NR, Lee HJ, Ryu HW,
Kim JW, Sohn KY, Kim HJ, Han YH and Oh SR: Protective effect of
EC-18, a synthetic monoacetyldiglyceride on lung inflammation in a
murine model induced by cigarette smoke and lipopolysaccharide. Int
Immunopharmacol. 30:62–68. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yoo N, Lee HR, Shin SH, Sohn KY, Kim HJ,
Han YH, Chong S, Kim MH, Yoon SY and Kim JW: PLAG
(1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol) augments the
therapeutic effect of pegfilgrastim on gemcitabine-induced
neutropenia. Cancer Lett. 377:25–31. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lee HR, Yoo N, Kim JH, Sohn KY, Kim HJ,
Kim MH, Han MY, Yoon SY and Kim JW: The therapeutic effect of PLAG
against oral mucositis in hamster and mouse model. Front Oncol.
6:2092016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jeong J, Kim YJ, Lee DY, Moon BG, Sohn KY,
Yoon SY and Kim JW: 1-Palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol
(PLAG) attenuates gemcitabine-induced neutrophil extravasation.
Cell Biosci. 9:42019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Karagiannis GS, Condeelis JS and Oktay MH:
Chemotherapy- induced metastasis: Mechanisms and translational
opportunities. Clin Exp Metastasis. 35:269–284. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zheng H, Yang Y, Hong YG, Wang MC, Yuan
SX, Wang ZG, Bi FR, Hao LQ, Yan HL and Zhou WP: Tropomodulin 3
modulates EGFR-PI3K-AKT signaling to drive hepatocellular carcinoma
metastasis. Mol Carcinog. 58:1897–1907. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhou X, Xie S, Wu S, Qi Y, Wang Z, Zhang
H, Lu D, Wang X, Dong Y, Liu G, et al: Golgi phosphoprotein 3
promotes glioma progression via inhibiting Rab5-mediated
endocytosis and degradation of epidermal growth factor receptor.
Neuro-oncol. 19:1628–1639. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ng EL, Gan BQ, Ng F and Tang BL: Rab
GTPases regulating receptor trafficking at the late
endosome-lysosome membranes. Cell Biochem Funct. 30:515–523. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li L, Fan P, Chou H, Li J, Wang K and Li
H: Herbacetin suppressed MMP9 mediated angiogenesis of malignant
melanoma through blocking EGFR-ERK/AKT signaling pathway.
Biochimie. 162:198–207. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Begley MJ, Yun CH, Gewinner CA, Asara JM,
Johnson JL, Coyle AJ, Eck MJ, Apostolou I and Cantley LC:
EGF-receptor specificity for phosphotyrosine-primed substrates
provides signal integration with Src. Nat Struct Mol Biol.
22:983–990. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Goh LK and Sorkin A: Endocytosis of
receptor tyrosine kinases. Cold Spring Harb Perspect Biol.
5:a0174592013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Merrifield CJ and Kaksonen M: Endocytic
accessory factors and regulation of clathrin-mediated endocytosis.
Cold Spring Harb Perspect Biol. 6:a0167332014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lyle CL, Belghasem M and Chitalia VC:
c-Cbl: An important regulator and a target in angiogenesis and
tumorigenesis. Cells. 8:4982019. View Article : Google Scholar
|
|
33
|
Gucwa AL and Brown DA: UIM
domain-dependent recruitment of the endocytic adaptor protein Eps15
to ubiquitin-enriched endosomes. BMC Cell Biol. 15:342014.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Garvalov BK, Foss F, Henze AT, Bethani I,
Gräf-Höchst S, Singh D, Filatova A, Dopeso H, Seidel S, Damm M, et
al: PHD3 regulates EGFR internalization and signalling in tumours.
Nat Commun. 5:55772014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Tong D, Liang YN, Stepanova AA, Liu Y, Li
X, Wang L, Zhang F and Vasilyeva NV: Increased Eps15 homology
domain 1 and RAB11FIP3 expression regulate breast cancer
progression via promoting epithelial growth factor receptor
recycling. Tumour Biol. 39:10104283176910102017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yuan W, Liu B, Wang X, Li T, Xue H, Mo X,
Yang S, Ding S and Han W: CMTM3 decreases EGFR expression and
EGF-mediated tumorigenicity by promoting Rab5 activity in gastric
cancer. Cancer Lett. 386:77–86. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Guerra F and Bucci C: Multiple roles of
the small GTPase Rab7. Cells. 5:342016. View Article : Google Scholar
|
|
38
|
Mukherjee R, Das A, Chakrabarti S and
Chakrabarti O: Calcium dependent regulation of protein
ubiquitination-Interplay between E3 ligases and calcium binding
proteins. Biochim Biophys Acta Mol Cell Res. 1864:1227–1235. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Sasaki T, Hiroki K and Yamashita Y: The
role of epidermal growth factor receptor in cancer metastasis and
microenvironment. BioMed Res Int. 2013:5463182013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Suen KM, Lin CC, Seiler C, George R,
Poncet-Montange G, Biter AB, Ahmed Z, Arold ST and Ladbury JE:
Phosphorylation of threonine residues on Shc promotes ligand
binding and mediates crosstalk between MAPK and Akt pathways in
breast cancer cells. Int J Biochem Cell Biol. 94:89–97. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Majumder A, Ray S and Banerji A: Epidermal
growth factor receptor-mediated regulation of matrix
metalloproteinase-2 and matrix metalloproteinase-9 in MCF-7 breast
cancer cells. Mol Cell Biochem. 452:111–121. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Saby C, Collin G, Sinane M, Buache E, Van
Gulick L, Saltel F, Maquoi E and Morjani H: DDR1 and MT1-MMP
expression levels are determinant for triggering BIK-mediated
apoptosis by 3D type I collagen matrix in invasive basal-like
breast carcinoma cells. Front Pharmacol. 10:4622019. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Cepeda MA, Evered CL, Pelling JJH and
Damjanovski S: Inhibition of MT1-MMP proteolytic function and
ERK1/2 signalling influences cell migration and invasion through
changes in MMP-2 and MMP-9 levels. J Cell Commun Signal.
11:167–179. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Masutani H, Yoshihara E, Masaki S, Chen Z
and Yodoi J: Thioredoxin binding protein (TBP)-2/Txnip and
α-arrestin proteins in cancer and diabetes mellitus. J Clin Biochem
Nutr. 50:23–34. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Lee HR, Shin SH, Kim JH, Sohn KY, Yoon SY
and Kim JW: 1-Palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol (PLAG)
rapidly resolves LPS-induced acute lung injury through the
effective control of neutrophil recruitment. Front Immunol.
10:21772019. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Kim GT, Hahn KW, Sohn KY, Yoon SY and Kim
JW: PLAG enhances macrophage mobility for efferocytosis of
apoptotic neutrophils via membrane redistribution of P2Y2. FEBS J.
286:5016–5029. 2019. View Article : Google Scholar : PubMed/NCBI
|
